Penn Pharma will invest $22 million in its South Wales, UK facility to expand its high containment facilities with a 15,000-sq.-ft. new development and commercial manufacturing unit for tablets and capsules. Penn Pharma’s chief executive officer, Dr. Richard Yarwood, said, “We are delighted to announce this significant investment in the UK pharmaceutical manufacturing sector at a time when the established industry remodels itself and outsourcing is on the increase. This investment i...